Literature DB >> 32282551

Trauma and Suicide: A Pilot Study Assessing Risk in Adults Diagnosed With Schizophrenia Spectrum Disorders.

Adrienne Reid Allen1, Kathryn M Hagen2.   

Abstract

This pilot study explored suicide risk in patients suffering from trauma and psychosis. Forty-seven participants diagnosed with schizophrenia spectrum disorders participated in the study. An archival design was used to identify the severity of suicide risk in participants with trauma and psychosis. Data included a chart review of documented trauma and responses to the Childhood Experience of Care and Abuse Questionnaire, Columbia-Suicide Severity Rating Scale, Beck Depression Inventory-II, and the Positive and Negative Syndrome Scale. Results of a linear regression indicated that chart-documented trauma and heightened depression scores were predictive of increased suicidality. Results suggest that, for patients with schizophrenia, depression severity and chart-documented trauma may be strong predictors of suicidality. Interestingly, data also revealed that, although depression and trauma were predictors of suicidality, psychosis was not. The implications of these results are discussed, in addition to suggestions for future research.

Entities:  

Year:  2020        PMID: 32282551     DOI: 10.1097/NMD.0000000000001144

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  2 in total

1.  Suicide Risk and Association With the Different Trauma During the COVID-19 Pandemic Period: A Cross-Sectional Study on Adolescent With Different Learning Stage in Chongqing, China.

Authors:  Yao Yu; Tingting Wu; Shanshan Wang; Weiwei Liu; Xin Zhao
Journal:  Front Public Health       Date:  2022-04-28

2.  Self-Transcendence Mediates the Relationship between Early Trauma and Fatal Methods of Suicide Attempts.

Authors:  Jeong Hun Yang; Sang Jin Rhee; C Hyung Keun Park; Min Ji Kim; Daun Shin; Jae Won Lee; Junghyun Kim; Hyeyoung Kim; Hyun Jeong Lee; Kyooseob Ha; Yong Min Ahn
Journal:  J Korean Med Sci       Date:  2021-02-01       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.